| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $76,118 | $80,187 | $82,006 | $84,039 | $84,284 |
| Gross Profit | $39,010 | $38,030 | $39,246 | $43,191 | $43,120 |
| Operating Income | $17,986 | $17,813 | $18,134 | $18,545 | $20,451 |
| Net Income | $14,306 | $14,742 | $14,653 | $14,879 | $15,974 |

Edwyn
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $76,118 | $80,187 | $82,006 | $84,039 | $84,284 |
| Gross Profit | $39,010 | $38,030 | $39,246 | $43,191 | $43,120 |
| Operating Income | $17,986 | $17,813 | $18,134 | $18,545 | $20,451 |
| Net Income | $14,306 | $14,742 | $14,653 | $14,879 | $15,974 |
Over the five-year period, Procter & Gamble Company demonstrated overall stability with modest revenue and profitability improvements. Revenues increased from USD 76.1 billion in 2021 to approximately USD 84.3 billion in 2024, before slightly tapering to USD 84.3 billion in 2025. This steady, rather than exponential, growth suggests consistent market demand amid competitive pressures in the consumer goods industry. Gross profit figures, however, exhibited some variability—dropping from USD 39.0 billion in 2021 to USD 38.0 billion in 2022 before recovering to over USD 43.1 billion in 2024—hinting at potential fluctuations in cost management or product mix. No year-over-year change exceeded the 20% threshold, underscoring a pattern of steady operational performance. Operating income and net income trends further reinforce a picture of cautious yet sustained growth. Operating income edged up from USD 17.99 billion in 2021 to USD 20.45 billion in 2025, with a notable increase from 2024 to 2025, suggesting operational improvements or better margin management during that period. Net income, following a similar modest upward trajectory—from USD 14.31 billion in 2021 to USD 15.97 billion in 2025—indicates controlled expenses and resilience despite external market fluctuations. In the context of the highly competitive consumer staples sector, these consistent performance metrics suggest that Procter & Gamble maintains strong financial health and sustainability, successfully balancing steady revenue growth with effective expense management and operational efficiencies.
This analysis is for informational purposes only and does not constitute financial advice or recommendations for any investment decisions. Please consult with a qualified financial professional for personalized guidance.